Determinants of a normal (versus impaired) oral glucose tolerance after combined pancreas-kidney transplantation in IDDM patients

Diabetologia

Volumn 39, Issue 4, 1996, Pages 462-468

  Pfeffer, F ^a   Nauck, M A ^b   Benz, S ^c   Gwodzinski, A ^c   Zink, R ^c   Busing M ^b   Becker, H D ^c   Hopt, U T ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Glucagon stimulation; Insulin secretion; Oral glucose tolerance; Pancreas transplantation; Pancreatic hormones

Indexed keywords

AMYLASE; AZATHIOPRINE; C PEPTIDE; CYCLOSPORIN A; GLUCAGON; GLUCOSE; HLA ANTIGEN; HLA DR ANTIGEN; INSULIN; PREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MULTIPLE REGRESSION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL;

ADULT; ALPHA-AMYLASE; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD GROUP INCOMPATIBILITY; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; GLUCAGON; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; REFERENCE VALUES; REGRESSION ANALYSIS; TIME FACTORS;

EID: 0029917933     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00400678     Document Type: Article

References (35)

1. Robertson RP (1991) Pancreas transplantation in humans with diabetes mellitus. Diabetes 40: 1085-1089
2. Sutherland DER (1992) Pancreas transplantation: indications and outcomes. Acta Diabetol 28: 185-188
3. Editorial (1990) Transplantation or insulin? Lancet 335: 1371-1372
4. Östman J, Bolinder J, Gunnarsson R, Brattström C, Tyden G, Wahren J, Groth CG (1989) Effects of pancreas transplantation on the metabolic and hormonal profiles in IDDM patients. Diabetes 38 [Suppl 1]:88-93
5. Pozza G, Bosi E, Secchi A et al. (1985) Metabolic control in type 1 (insulin-dependent) diabetes after pancreas transplantation. BMJ 291: 510-513
6. Nghiem D, Corry R (1987) Technique of simultaneous renal-pancreaticoduodenal transplantation with urinary drainage of pancreatic secretion. Am J Surg 153: 405-406
7. Hopt UT, Büsing M, Schareck WD, Becker HD (1991) The bladder drainage technique in pancreas transplantation: the Tübingen experience. Diabetologia 34 [Suppl 1]: 24-28
8. Landgraf R, Nusser J, Müller W et al. (1989) Fate of late complications in type 1 diabetic patients after successful pancreas-kidney transplantation. Diabetes 38 [Suppl 1]: 33-37
9. World Health Organization (1985) Technical report series No. 727
10. Nauck M, Büsing M, Siegel EG et al. (1991) Consequences of systemic venous drainage and denervation of heterotopic pancreatic transplants for insulin/C-peptide profiles in the basal state and after oral glucose. Diabetologia 34 [Suppl 2]:81-85
11. Kalz H, Homan M, Velosa J, Robertson P, Rizza R (1991) Effects of pancreas transplantation on postprandial glucose metabolism. N Engl J Med 325: 1278-1283
12. Nauck MA, Büsing M, Siegel EG et al. (1992) Basal and nutrient-stimulated pancreatic and gastrointestinal hormone concentrations in type-1 diabetic patients after successful combined pancreas and kidney transplantation. Clin Invest 70: 40-48
13. Nauck MA, Büsing M, Ørskov C et al. (1993) Preserved incretin effect in type 1-diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation. Acta Diabetol 30: 39-45
14. Pfeffer F, Büsing M, Zink R, Gwodzinski A, Makowiec F (1994) High graft survival and excellent endocrine function after combined pancreas-kidney transplantation: results of a standardized protocol. Transplant Proceed 26: 471-472
15. Conard V, Franckson JRM, Bastenie PA, Kestens J, Kovaks L (1953) Etude critique du triangle d' hyperglycémie intraveneux chez l'homme normale et détermination d' un coefficient d' assimilation glycidique. Arch Int Pharmacodyn 93: 277-286
16. The Diabetes Control and Complication Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
17. Socci C, Falqui L, Davalli AM et al. (1991) Fresh human islet transplantation to replace endocrine function in type 1 diabetic patients. Acta Diabetol 28: 151-157
18. Pyzdrowski KL, Kendall DM, Halter JB, Nakhleh R, Sutherland DER, Robertson RP (1992) Preserved insulin secretion and insulin independence in recipients of islet autografts. N Engl J Med 327: 220-226
19. Landgraf R, Nusser J, Riepl RL, Fiedler F, Illner W-D, Abendroth D, Land W (1991) Metabolic and hormonal studies of type 1 (insulin-dependent) diabetic patients after successful pancreas and kidney transplantation. Diabelologia 34 [Suppl 1]: S61-S67
20. Golay A, Chen YD, Reaven GM (1986) Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals. J Clin Endocrinol Metab 62: 1081-1088
21. Lillioja S, Mott DM, Howard BV et al. (1988) Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318: 1217-1225
22. Mitrakou A Kelley D, Mokan A, Veneman T, Pangburn T, Reilly J, Gerich J (1992) Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326: 22-29
23. Beard JC, Halter JB, Best JD, Pfeiffer MA, Porte D Jr (1984) Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men. Am J Physiol 247: E592-E596
24. Pagano G, Cavallo-Perin P, Cassader M et al. (1983) An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest 72: 1814-1820
25. Luzi L, Secchi A, Facchini F et al. (1990) Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia 33: 549-556
26. Büsing M, Hopt UT, Quaken M, Becker HD, Morgenroth K (1993) Morphological studies of graft pancreatitis following pancreas transplantation. B J Surg 80: 1170-1173
27. Henry ML, Osei K, O'Dorioso TM, Tesi RJ, Ferguson RM (1991) Concomitant reduction in urinary amylase and acute first phase insulin release predict pancreatic allograft rejection in type 1 diabetic recipients. Clin Transpl 5: 112-120
28. Tydén G, Reinholt F, Bohmann SD, Brattström C, Tibell A, Groth CG (1989) Diagnosis of pancreatic graft rejection by pancreatic juice cytology. Transplant Proc 21: 2780-2781
29. Elahi D, McAllon-Dyke M, Clark B et al. (1993) Sequential evaluation of islet cell responses to glucose in the transplanted pancreas in humans. Am J Surg 165: 15-22
30. Jarrett RJ, Keen H, Fuller JH, McCartney M (1979) Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes"). Diabetologia 16: 25-30
31. Keen H, Jarrett RJ, McCartney P (1982) The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia 22: 73-78
32. Jarrett RJ, McCartney P, Keen H (1982) The Bedford survey: ten-year mortality rate in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetes. Diabetologia 22: 79-84
33. Faber OK, Binder C (1977) C-peptide response to glucagon - a test for the residual β cell function in diabetes mellitus. Diabetes 26: 605-610
34. Madsbad S, Krarup T, McNair P, Christiansen C, Faber OK, Transbøl I, Binder C (1981) Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand 210: 153-156
35. Cottrell DA, Henry ML, O'Dorioso, Tesi RJ, Ferguson RM, Osei K (1992) Sequential metabolic studies of pancreas allograft function in type 1 diabetic recipients. Diabet Med 9: 438-443